[Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms]

Area of Science:

• Oncology
• Biochemistry
• Clinical Diagnostics

Background:

• Bladder neoplasms are a significant health concern.
• Biomarkers like tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) are investigated for diagnostic and prognostic value.
• Acetylation phenotype and smoking are potential influencing factors in cancer development and progression.

Purpose of the Study:

• To investigate the influence of acetylation phenotype and smoking on serum TPA and CEA concentrations in bladder cancer patients.
• To compare TPA and CEA levels between bladder cancer patients and a control group.

Main Methods:

• Serum samples were collected from 76 patients with bladder neoplasms and 46 controls.
• Acetylation phenotype was determined for all participants.
• Serum concentrations of TPA and CEA were measured.
• Smoking habits were recorded for all subjects.

Main Results:

• A significant difference in TPA concentrations was observed between bladder cancer patients and the control group.
• No significant difference in CEA concentrations was found between the groups.
• In bladder cancer patients, both acetylation phenotype and smoking habit significantly affected serum TPA levels.

Conclusions:

• Acetylation phenotype and smoking are significant factors influencing TPA concentrations in bladder cancer patients.
• TPA may serve as a relevant biomarker in bladder neoplasm, potentially modulated by genetic and environmental factors.
• CEA does not appear to be significantly affected by these factors in this patient cohort.